Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 65.32%.However, over the last six months, we can see a weaker performance of 99.03%. Over the last 30 days, the price of AKBA has fallen by 25.77%. And in the last five days, it has surged by 12.64%.
Akebia Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $2.48 on 03/28/24, while the lowest price for the same period was registered at $0.80 on 06/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of AKBA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Akebia Therapeutics Inc’s current trading price is -17.34% away from its 52-week high, while its distance from the 52-week low is 156.25%. The stock’s price range during this period has varied between$0.80 and $2.48. The Akebia Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.89 million for the day, a figure considerably higher than their average daily volume of 1.8 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Akebia Therapeutics Inc (AKBA) has experienced a quarterly rise of 33.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 447.27M and boasts a workforce of 167 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4700, with a change in price of +1.1000. Similarly, Akebia Therapeutics Inc recorded 1,997,006 in trading volume during the last 100 days, posting a change of +116.24%.
AKBA Stock Stochastic Average
Akebia Therapeutics Inc’s raw stochastic average for the past 50 days is presently 94.19%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 89.36%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 78.41% and 67.78%, respectively.
